From Market to Discovery and Back, the Value of Early Commercialization

Develop the right product for tomorrow by leveraging relationships between sciences, sales and marketing.

Event Details


swissnex San Francisco
730 Montgomery St., San Francisco, 94111 United States


September 25, 2007 from 6:30 am to 8:30 am America/Los Angeles (UTC-08:00)


$20 FACC Members / $25 Non-members / $30 at the door

Together with the French-American Chamber of Commerce in San Francisco, swissnex is pleased to bring you another informative event in our ongoing series, “Life Science Breakfasts”.

Due to increased competition and difficulty in bringing new and innovative products to market, aligning R&D; and commercial functions has been an area of increasing focus for the last 15 years.  The industry has been forced to define ways to address these challenges and ensure that scarce R&D; and commercial resources are focused on the most commercially viable targets. Attempts to address these challenges have resulted in various models incorporating cross-functional project teams, aligning around a therapeutic area, or establishing cross-functional portfolio decision-making bodies.

This session will cover the drivers for early commercialization models improvements, explore the paradoxes it can create and what it takes to develop the right product for tomorrow leveraging relationships between sciences, sales and marketing.


7:30 am breakfast and networking
8:00 am program with speakers including:
Jean-Marc Niemetz, Vice President of Global Life Science, Capgemini;
Kristi Jones, Director of Sales, Genentech


Photo: Myleen Hollero